View Original Article<\/a> \t<\/p>\n","protected":false},"excerpt":{"rendered":"KannaLife Sciences was mentioned in an article by Life Science Leader written by Cliff Mintz about the companies cannabis-based pharmaceutical products and how it could be the next frontier of medical products. “Unlike medical marijuana companies, biopharmaceutical companies, including GW Pharma, Kannalife Sciences, Aphios, and others, are committed to developing cannabis-derived pharmaceuticals using conventional U.S. […]<\/p>\n","protected":false},"author":1,"featured_media":3518,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[3,163,162],"tags":[179],"class_list":["post-3517","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","category-kannalife-sciences","category-media-coverage","tag-kannalife-sciences"],"yoast_head":"\n
Cannabis-Based Pharmaceuticals | Medical Marijuana Inc.<\/title>\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\n\n\n\n\n\t\n\t\n\t\n